Over the past few weeks, the Louna Aesthetics team had the opportunity to participate in two major Aesthetics Summit gatherings dedicated to aesthetic medicine and regenerative medicine, first in Amsterdam, then in London.
These events brought together physicians, researchers, distributors, and industry experts to exchange insights on the future of skin regeneration, injectables, exosome technologies, and advanced aesthetic treatments.
For Louna Aesthetics, these moments are essential. Beyond product presentations, they create valuable opportunities to connect directly with practitioners, understand clinical expectations, and discuss the evolving needs of modern aesthetic medicine.
Our journey first began in Amsterdam alongside our distributor and a selected group of physicians for several days dedicated to clinical exchange and product experience.
This event allowed us to present:
The sessions included presentations by Dr. Marco Cerrano, as well as valuable clinical insights shared by Dr. Saed Alhabib regarding his experience with Innovyal products in daily practice.
These discussions highlighted the growing importance of:
For Louna Aesthetics, direct interaction with practitioners remains a fundamental part of innovation. Understanding real clinical challenges allows us to continuously refine our formulations and ensure they meet the highest standards of safety, efficacy, and patient satisfaction.
Discover more about Louna Fillers and Innovyal
Following Amsterdam, our team continued to London to participate in discussions surrounding one of the most rapidly evolving fields in regenerative aesthetics: exosome technologies and advanced cellular communication.
Led by Alexandre Porcello, PhD, and Cíntia Marques, PhD, our scientific session explored the complexity behind exosome-based solutions, addressing key topics such as:
At the center of these discussions was Exovyal, our Swiss-made polyrevitalizing complex developed with Dual Exosomes Technology.
Designed to support:
Exovyal reflects our commitment to combining scientific precision with clinical performance.
The exchanges during this event confirmed an important reality in regenerative medicine: not all exosome technologies are created equal. Manufacturing standards, purification processes, formulation stability, and biological consistency remain critical factors in achieving reliable clinical outcomes.
More about Exovyal here.
These international events reinforce the importance of collaboration between science, clinical practice, and innovation.
We are grateful for every exchange, every discussion, and every opportunity to share our vision of regenerative aesthetics with physicians and partners around the world.
We look forward to continuing these conversations during future congresses, trainings, and scientific meetings.